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Biological diversity among mammals is remarkable.
Mammalian body weights range seven orders of
magnitude and lifespans differ more than 100-fold
among species. While genetic, dietary, and pharma-
cological interventions can be used to modulate
these traits in model organisms, it is unknown how
they are determined by natural selection. By profiling
metabolites in brain, heart, kidney, and liver tissues
of 26 mammalian species representing ten taxonom-
ical orders, we report metabolite patterns character-
istic of organs, lineages, and species longevity. Our
data suggest different rates of metabolite divergence
across organs and reveal patterns representing
organ-specific functions and lineage-specific physi-
ologies. We identified metabolites that correlated
with species lifespan, some of which were previously
implicated in longevity control. We also compared
the results with metabolite changes in five long-lived
mouse models and observed some similar patterns.
Overall, this study describes adjustments of the
mammalian metabolome according to lifespan, phy-
logeny, and organ and lineage specialization.
INTRODUCTION
All modern mammals descend from a common ancestor that
lived 210 million years ago and have since undergone remark-
able diversification in morphology, life history, and other charac-
teristics. Their body parts, such as tongues, ears, fingers, and
feet, have been modified for numerous functions including332 Cell Metabolism 22, 332–343, August 4, 2015 ª2015 Elsevier Incnectar-feeding, echolocating, swimming, flying, and digging;
their body weights range from under 2 g (Etruscan shrew, Sun-
cus etruscus) to over 150 tons (blue whale, Balaenoptera muscu-
lus); and their maximum lifespans differ by more than 100-fold
(Tacutu et al., 2013). Many of the traits affecting development,
body weight, and lifespan (i.e., the life history traits) are often
correlated. Longer-lived species tend to be bigger, produce
fewer offspring, growmore slowly, and have lowermass-specific
metabolic rates (Peters, 1986; Sacher, 1959; Western, 1979),
indicative of modulation by the same underlying evolutionary
forces. Certain lineages, such as bats (Seim et al., 2013) and pri-
mates, have evolved to live longer as a whole, whereas other in-
stances of exceptional longevity have emerged sporadically
among short-lived taxonomic relatives such as the naked mole
rat, Heterocephalus glaber, which lives ten times longer than
other rodents of comparable size (Buffenstein, 2008; Fang
et al., 2014; Kim et al., 2011).
Longevity is elastic and can vary along a continuum, but
the underlying factors are only starting to be characterized.
Research in model organisms revealed several important molec-
ular players, such as insulin-like growth factor 1 (IGF-1) (Fried-
man and Johnson, 1988; Holzenberger et al., 2003; Tatar et al.,
2001), mechanistic target of rapamycin (mTOR) (Kenyon, 2010;
Vellai et al., 2003), and sirtuins (Lin et al., 2000; Tissenbaum
and Guarente, 2001). Dietary and pharmacological interventions
can also extend lifespan in diverse organisms (Harrison et al.,
2009; McCay et al., 1935; Weindruch et al., 1986). In particular,
the lifespan of laboratory mice can be increased by restriction
of food or methionine (Flurkey et al., 2010; Sun et al., 2009),
administration of rapamycin (Harrison et al., 2009; Miller et al.,
2014) or acarbose (Harrison et al., 2014), or certain genetic
mutations (Ladiges et al., 2009). Rapamycin, an inhibitor of
mTORC1, leads to a 23%–26% increase in the median lifespan
of mice (Miller et al., 2014). Acarbose inhibits glycoside hydro-
lases (the enzymes that digest complex carbohydrates to.
Figure 1. Diversification of Mammals
(A) Maximum lifespan correlates positively with body mass. Maximum lifespan (years) was plotted against adult weight (g) on log10 scale for 995 mammalian
species from AnAge database (Tacutu et al., 2013), color-coded by taxonomical orders. Human, the naked mole rat, and the Brandt’s bat are highlighted. To
simplify the color scheme, Artiodactyla and Perissodactyla were grouped together, and Ericomorpha and Soriceomorpha were grouped together.
(B) Phylogeny of the mammals examined in the current study. Branches and tips are colored according to taxonomical orders (same color scheme as in A).
Divergence times were based on previous estimates (Fushan et al., 2015; Meredith et al., 2011). Animal silhouettes are for illustration only.absorbable sugars in the gastrointestinal tract) and is used
clinically to blunt post-prandial glucose surges in diabetic pa-
tients. It seems plausible that limiting peak glucose concentra-
tions may explain its longevity benefits. Mutant strains such as
Snell dwarf (defective in anterior pituitary development) (Flurkey
et al., 2001) and growth hormone receptor knockout (GHRKO)
(Coschigano et al., 2003) are also long-lived, due to altered
signaling in growth hormone (GH) itself or throughGH-stimulated
production of IGF-1.
How longevity is modulated during evolution to produce both
long-lived and fit animals, however, is still unclear. Lifespan is an
inherent characteristic of a species and remains relatively stable
through generations, but it can also change in either direction
over time. In order to vary lifespan on an evolutionary timescale,
a number of biological pathways may need to be altered, re-
wired, or reprogrammed. Omics-scale comparative studies
across multiple species are instrumental in understanding the
evolution of mammalian genomes and gene expression (Bra-
wand et al., 2011; Lindblad-Toh et al., 2011). To gain insights
into the metabolic basis of mammalian diversity and longevity,
we quantified metabolite levels in brain, heart, kidney, and liver
tissues of 26 species of mammals and identified metabolites
with organ-, lineage-, and trait-specific patterns. We described
the metabolite divergence and distribution in different organs,
linked the lineage-specificmetabolic patterns to lineage-specific
physiologies, and identifiedmetabolites with positive or negative
correlation to longevity traits. In addition, we profiled the metab-Celolites in brain and liver of five long-lived mouse models (caloric
restriction, rapamycin treatment, acarbose treatment, GHRKO,
and Snell dwarf) and compared the observed changes with the
mammalian longevity signatures. Our study provides the first
glimpse into how metabolism may have been altered to modu-
late mammalian lifespan.
RESULTS
Metabolite Conservation and Divergence amongOrgans
We applied targeted metabolite profiling to quantify the metabo-
lite levels in brain, heart, kidney, and liver tissues of 26 species of
mammals, representing ten taxonomical orders and covering a
wide range of longevity-associated traits (Figure 1; Table S1A).
The species were matched by biological age (all young adults)
and sex (all were males, except for horse and vervet). Biological
replicates (i.e., samples from multiple individuals of a species)
were collected for most of the species (Table S1A). In total,
162 water-soluble metabolites and 100 lipids were reliably de-
tected across 235 samples. Data quality was assessed graphi-
cally (Figure S1).
Principal-component analysis revealed the samples segre-
gated predominantly by organ origin, with most of the replicates
clustering together and the first three principal components ac-
counting for 50% of the total variance (Figure 2A). ANOVA
confirmed that organ and species accounted for over 80%
of the variation in individual metabolite levels, whereas thel Metabolism 22, 332–343, August 4, 2015 ª2015 Elsevier Inc. 333
Figure 2. Metabolite Divergence in Mam-
malian Organs
(A) Samples segregate predominantly according
to organ origin. Values in parenthesis indicate the
percentage of variance explained by each of the
first three principal components (PCs). Biological
replicates were treated as individual points.
(B) Brain samples show highest Spearman corre-
lation coefficients. The box plot shows the pair-
wise correlation among the samples in each
organ. Wilcoxon rank sum test p value < 23 1016
for brain against each of the other organs.
(C and D) Brain has the largest percentage of
metabolites with high phylogenetic signals. In (C),
only Pagel’s lambda > 0.6 are shown. In (D), the
dotted line indicates Blomberg’s K = 1.0.differences between replicates were much smaller than the dif-
ferences between species (Figure S1). The clustering pattern
agreed with those based on mammalian gene expression pro-
files (Brawand et al., 2011; Fushan et al., 2015), suggesting
that metabolite levels and organ-specific metabolism were
generally well conserved across the mammals.
The phylogenetic relationship of many mammals has been es-
tablished based on fossil and molecular evidence (Figure 1B)
(Fushan et al., 2015; Meredith et al., 2011). To determine if their
metabolite levels recapitulate this relationship, we constructed
phylograms using the metabolite levels in each organ and found
them largely consistent with the reference phylogeny (Fig-
ure S2A). The brain phylogram had the shortest tip-to-root
branch lengths (Figures S2B and S2C), indicative of small degree
of metabolite divergence (Brawand et al., 2011). The brain sam-
ples also showed highest Spearman correlation coefficients (Fig-
ure 2B) and had the largest proportion of metabolites with high
phylogenetic signals (i.e., Pagel’s lambda > 0.9; Pagel, 1999;
and Blomberg’s K > 1; Blomberg et al., 2003; Figures 2C and
2D), suggesting that brain metabolites are most conserved
among the four organs and have evolved largely according to
the phylogeny. In contrast, themetabolites in the other examined
organs diverge to a much greater extent, possibly due to stron-
ger environmental influence or other selection pressures.
Metabolite Profiles Reflect Organ Functions
The metabolite profile of an organ is expected to reflect its bio-
logical functions. We visualized the distribution of metabolites
on a heatmap (Figure 3A) and used the Wilcoxon rank sum test
to identify metabolites selectively enriched or depleted in a
particular organ (in comparison with at least two other organs;
Table S2A).
18 out of the 19 proteinogenic amino acidsmeasured (cysteine
was not quantified) were found at moderate to high levels in kid-334 Cell Metabolism 22, 332–343, August 4, 2015 ª2015 Elsevier Inc.ney relative to the other organs (Table
S2B), likely due to reabsorption at the
renal proximal tubule. One exception
was glutamine (Figure 3B), which is
routinelymetabolized by the kidney for ni-
trogen disposal and acid-base balance.
Glutamine is broken down to ammonia
and glutamate, helping to remove exces-sive protons and generate bicarbonate ions (van de Poll et al.,
2004).
The metabolite profile of the heart largely reflected its energy
demand. Heart tissue was depleted of amino acids and many
other metabolites but enriched with acylcarnitines (especially
short-chain acylcarnitines; Figure 3C) and triacylglycerols
(TAGs). Acylcarnitines help transport fatty acids across mito-
chondrial inner membranes (Vaz and Wanders, 2002), whereas
carnitine acts as an acetyl group acceptor, buffering the cellular
pool of coenzyme A (CoA) and preventing inhibition of pyruvate
dehydrogenase, especially in tissues dependent on beta-oxida-
tion (Hoppel, 2003).
In contrast, the brain normally relies on glucose for fuel and
contains relatively few TAGs. However, it had high concentra-
tions of glycerophospholipids and a number of sphinogmyelins
(Figure 3D), which are both key constituents of animal cell mem-
branes. In particular, sphingomyelins are mainly found in the
myelin sheaths surrounding nerve cell axons. The neurotransmit-
ters gamma-aminobutyric acid (GABA) and glutamate were also
present at high levels.
Liver was enriched with a wide range of metabolites, including
amino acids, glycerophospholipids, carbohydrates, and steroids
(Table S2B). Some of them were significantly higher than in the
other organs, likely indicative of liver-specific pathways. For
example, sucrose and lactose were found at very high concen-
trations in liver (Figure 3E), as these sugars are not routinely
utilized by the other organs. Bile acid components such as gly-
cocholate, taurocholate, taurodeoxycholate, and taurocheno-
deoxycholate were restricted mostly to liver (Figure 3E), since
primary bile acids are synthesized by liver cells from cholesterol.
We grouped lipids according to LIPID MAPS Classification
System (Experimental Procedures) (Fahy et al., 2007). Within
each category, we compared the relative percentage abundance
of individual lipids in our study with those previously reported in
Figure 3. Distribution of Metabolites across the Organs
(A) The overall pattern visualized on a heat map. Hierarchical clustering was performed on standardized concentrations using average linkage. Each row rep-
resents one metabolite, and each column represents one biological sample. Selected classes of metabolites are highlighted.
(B) Kidney is depleted of glutamine. Each box represents the range of standardized concentrations for a particular amino acid in kidney across the mammals.
(C) Heart is enriched with carnitine and short-chain acylcarnitines. The alternative names are acetylcarnitine (C2 carnitine), propionylcarnitine (C3 carnitine), and
malonylcarnitine (C3-DC carnitine).
(D) Brain is enriched with sphingomyelins (SM) and the neurotransmitter gamma-aminobutyric acid (GABA).
(E) Liver has high levels of sucrose, lactose, and bile acid components.human plasma (Quehenberger et al., 2010). Significant correla-
tions were observed for TAG, lysophosphatidylcholine (LPC),
phosphatidylcholine (PC), and cholesteryl ester (CE) (see
Experimental Procedures for lipid classification and abbrevia-
tions; Table S2D), suggesting that the overall lipid composition
was conserved across mammals.
Metabolites with Lineage-Specific Changes
Since a particular lineage of mammals often exhibits biological
and physiological features distinctive from the others, we group-
ed the species by taxonomic orders or families and applied
phylogenetic ANOVA (Garland et al., 1993) to determine if the
concentration of a metabolite in one group was significantly
different from the other groups (Table S3).
Bats (order Chiroptera) showed significantly reduced levels
of methionine sulfoxide in both kidney and liver (phylogenetic
ANOVA p value = 0.003 in kidney and 0.002 in liver; TableCelS3A), while their methionine levels were typical of other
mammals (Figure 4A). Methionine sulfoxide is produced by
oxidation of methionine by reactive oxygen species (ROS),
and in most species, its level increases during aging or oxida-
tive stress (Berlett and Stadtman, 1997). Bats are the longest-
lived mammalian order after controlling for the effect of
body size, and there is evidence that they produce less
ROS and are more resistant to oxidative stress. For example,
cave Myotis bats and Mexican free-tailed bats (both with
maximum lifespan potential of 12 years) show lower protein
carbonylation and ubiquitination in liver than mice, and their
cells are more resistant to protein oxidation (Salmon et al.,
2009; Shi et al., 2010). Mitochondria from bat heart also pro-
duce less hydrogen peroxide than those from shrew and
white-footed mouse (Brunet-Rossinni, 2004), although the
differences are less than the divergence in their maximum
lifespans (Buffenstein et al., 2008). Hence, low methioninel Metabolism 22, 332–343, August 4, 2015 ª2015 Elsevier Inc. 335
Figure 4. Metabolite Patterns Reflect Species Physiology
(A) Bats have low levels of methionine sulfoxide in liver. The error bars indicate SEs (only for those with biological replicates). The species are colored according to
taxonomical orders (same color scheme as in Figure 1A). The bars representing the bats are shaded.
(B) African mole rats have low levels of allantoin in kidney and liver. The bars representing the naked mole rat and Damaraland mole rat are shaded.
(C) Liver allantoin levels correlate positively with uricase expression. The error bars indicate SEs in gene expression measurements (horizontal direction) or in
metabolite measurements (vertical direction). The correlation relationship is robust (correlation coefficients using all points: Pearson = 0.86, Spearman = 0.78;
excluding naked mole rat: Pearson = 0.76, Spearman = 0.74). Gene expression data were not available for Damaraland mole rat.
(D) Use of taurine and glycine for bile acid conjugation among the mammals. The species with known conjugated strategy are highlighted. Square (-), taurine-
conjugation only; triangle (:), glycine-conjugation only; circle (C); both taurine- and glycine-conjugation; cross (3), conjugation strategy unknown.sulfoxide levels are consistent with reduced oxidative stress
generally observed in bats.
Several genetic and physiological features of African mole rats
(family Bathyergidae) are distinct from those of other rodents
(Fang et al., 2014; Kim et al., 2011), so we compared Bathyergi-
dae against the other examined species (Table S3B), as well as
against the other rodents in this study (Table S3C). Several
metabolites were detected in both comparisons across multiple
organs, including enrichment of acetylglycine (in heart and liver),
enrichment of trimethylamine N-oxide (in brain and heart), and
depletion of allantoin (in brain, heart, kidney, and liver) (Fig-336 Cell Metabolism 22, 332–343, August 4, 2015 ª2015 Elsevier Incure 4B). This depletion of allantoin in the Bathyergidae is partic-
ularly striking, since other African rodents (in particular the
Cricetidae) excrete high levels of allantoin (Buffenstein et al.,
1985). Using the gene expression data for some of these
species (Fushan et al., 2015), we confirmed the positive correla-
tion between uricase expression and allantoin level in liver
(Pearson correlation coefficient = 0.86, Spearman correlation
coefficient = 0.78; Figure 4C), with particularly low expression
in the naked mole rat. In mammals, degradation of purine pro-
duces urate, which is then converted to allantoin by the enzyme
uricase and excreted in urine (Buffenstein et al., 1985; Ngo and.
Assimos, 2007). In humans and other higher primates, the gene
coding for uricase is a pseudogene and urate is excreted
instead. However, these genetic changes were not found in the
Africanmole rat enzymes, so the low uricase expression appears
to be achieved by a different mechanism.
Since the mammalian species used in this study include carni-
vores, insectivores, omnivores, and herbivores, we wondered if
the dietary preferences would also be reflected in the metabolic
profiles, especially in terms of different bile acid conjugates. Bile
acids can be conjugated with either taurine or glycine, depend-
ing on their concentrations in liver and affinities for the enzyme
bile acid CoA:amino acid N-acyltransferase. Most animals con-
jugate exclusively with taurine, whereas glycine conjugation is
limited to certain placental mammals and herbivores (Huxtable,
2002; Vessey, 1978). Indeed, in liver, the taurocholate:glycocho-
late ratio correlated positively with the taurine:glycine ratio (Pear-
son correlation coefficient = 0.74; Figure 4D). Rabbit and guinea
pig are known to employ glycine-conjugation only and had low
values for both ratios, while cat, being an obligate carnivore,
was high in both (Figure 4D). Based on the clustering pattern,
hedgehog and shrew (predominantly insectivores), as well as
animals belonging to order Carnivora, probably use taurine
conjugation only, whereas most rodents of the family Muridae
and animals of orders Artiodactyla and Perissodactyla use
both taurine and glycine conjugation (Figure 4D).
Metabolome Remodeling and Longevity Variation
Next, we examined the general trend in longevity and bodymass
across these species. We obtained the traits data from public
databases (Carey and Judge, 2000; Tacutu et al., 2013) and
focused primarily on adult weight (AW) and the longevity metrics
average lifespan (AL), maximum lifespan (ML), female time to
maturity (FTM), as well as their body-mass-adjusted residuals
(i.e., ALres, MLres, and FTMres, respectively) (Table S1A). While
AL and ML are most closely related to the concept of longevity,
FTM can be measured more easily and may be less prone to re-
porting bias. They also correlated strongly with one another
(Pearson correlation coefficient = 0.91 between AL and ML;
0.87 between AL and FTM; 0.84 between ML and FTM). Since
AW correlates positively with lifespan (Figure 1A), the longevity
residuals were computed to remove the body mass influence.
To account for the evolutionary relationship of the species, we
performed regression by phylogenetic generalized least squares
(Felsenstein, 1985; Grafen, 1989) (Table S4). Different models of
trait evolution were tested and within-species variations were
incorporated in the calculation (Supplemental Experimental Pro-
cedures). To assess the result robustness, we applied a two-step
verification procedure (Experimental Procedures). The results
were also adjusted for false discovery rate (‘‘q value’’) and tabu-
lated across the organs and traits (Table S4).
When the results were visualized on a heatmap (Figure 5A), a
few observations became apparent. Within each organ, the cor-
relations with the longevity metrics were largely consistent.
Although the reported lifespan data were obtained from different
databases andmight not be entirely accurate, they did not signif-
icantly affect the calculated correlation, suggesting the results
were robust to sample variation or slight measurement inaccu-
racy. On the other hand, the patterns were rather distinct across
the four organs, suggesting the metabolites in different organsCelmay follow different trajectories during evolution. By pooling
the top hits (p value.robust < 0.01) of the two sets of longevity
metrics (i.e., combining AL, ML, and FTM as one set; ALres,
MLres, and FTMres as the other set), a number of positively
and negatively correlating pathways were found to be enriched
in each organ (Figure 5B).
Body Mass and Longevity Signatures
With respect to AW, creatinine (Crn) showed significant positive
correlation in all four organs (p value.robust <108; Figure 5C). A
related metabolite, creatine (Cr), also emerged as a top hit in
heart and liver (Table S4). It is well known that urinary and serum
Crn levels increase with body mass (especially lean body mass)
(Forbes and Bruining, 1976), as most Crn is derived from Cr in
skeletal muscles and larger animals tend to have greater muscle
mass. On the other hand, several glycerophospholipids (e.g.,
C16:0 LPE, C22:6 LPE, C18:0 LPC, and C22:6 LPC) negatively
correlated with body mass, especially in brain and heart (Fig-
ure 5B; Table S4). A number of TAGs showed significant but
opposite trends in heart (positive correlation) and kidney (nega-
tive correlation) (Figure 5B).
In terms of the longevity traits, a negative correlation was
observed for amino acids, LPC, lysophosphatidylethanolamine
(LPE), and metabolites involved in thiamine metabolism,
whereas a positive correlation was observed mainly for sphingo-
myelin (SM) (Figure 5B). LPC and LPE are generated by
phospholipase-dependent hydrolysis of PC and phosphatidyl-
ethanolamine (PE), respectively. Phospholipase A2 (PLA2) activ-
ity releases fatty acids such as arachidonic acid from the sn-2
position of the glycerol backbone of phospholipids and is
commonly associated with inflammatory signaling inmammalian
tissues. For example, elevated circulating lipoprotein-associ-
ated PLA2 activity is linked to coronary artery disease in humans
(Rosenson and Stafforini, 2012), supporting a potential inverse
relationship between phospholipase activities (and hence LPC
and LPE levels) and longevity.
Similar to the situation with body mass, TAG as a whole
showed opposing trends to longevity in heart (positive) and kid-
ney (negative). Closer examination revealed that the negative
correlations in kidney were largely attributed to TAGwith polyun-
saturated fatty acid (PUFA) side chains (i.e., multiple double
bonds; Figure 5D), whereas the positive correlations in heart
were due to TAG with saturated or monounsaturated fatty acid
(MUFA) side chains. A recent study on human plasma lipidomes
of middle-aged offspring of nonagenarians revealed a signature
of 19 lipid species associating with female familial longevity,
including high levels of SM and low levels of PUFA TAG (Gonza-
lez-Covarrubias et al., 2013). Analysis of phospholipids in heart
of a number of mammals also revealed a negative correlation be-
tween double-bond content and ML (Pamplona et al., 2000).
Naked mole rat tissues contain much lower levels of docosahex-
aenoic-acid-containing (with six double bonds) phospholipids
compared to mouse (Mitchell et al., 2007). Since PUFAs are
particularly sensitive to peroxidation damage, the reduced level
of polyunsaturated TAG in long-lived species may reflect their
enhanced resistance to oxidative stress.
Allantoin correlated negatively with longevity in brain, kidney,
and liver, whereas urate showed some moderate positive corre-
lation (Table S4H). Furthermore, the urate:allantoin ratio showedl Metabolism 22, 332–343, August 4, 2015 ª2015 Elsevier Inc. 337
Figure 5. Metabolites Correlating with Body
Mass and Longevity
(A) Overview of correlation with body mass and
longevity. The grids represent the robust regres-
sion p value (‘‘p value.robust’’) betweenmetabolite
levels in each organ and the indicated traits (AW,
adult weight; AL, average lifespan; ML, maximum
lifespan; FTM, female time to maturity; ALres,
average lifespan residual; MLres, maximum life-
span residual; FTMres, female time to maturity
residual). Only p value.robust < 0.01 are shown in
color, with positive correlation in red and negative
correlation in blue. Selected classes of metabo-
lites are highlighted by rows (same color scheme
as in Figure 3A). See Table S4H for more details.
(B) Top pathways correlating with body mass
and longevity. The grids represent the pathway
enrichment analysis p values (only p values < 0.01
are shown in color), with positive correlation in red
and negative correlation in blue. For the purpose of
enrichment analysis, the top hits (p value.robust <
0.01) in AL, ML, and FTM were pooled together,
and the top hits in ALres, MLres, and FTMres were
also pooled together. ‘‘Monounsaturated TAG’’
refers to TAG with at most two double bonds in
total. ‘‘Polyunsaturated TAG’’ refers to TAG with
three or more double bonds. See Table S4J for
more details.
(C) Liver creatinine level correlates positively
with AW. The vertical error bars indicate SE. The
points are colored according to taxonomical
orders (same color scheme as in Figure 1A).
Regression p value.robust = 1.01 3 1010;
p value.max = 4.20 3 1010.
(D) Kidney C56:4 TAG level correlates negatively
with average lifespan. Regression p value.robust =
9.75 3 103; p value.max = 3.70 3 102.
(E) Kidney urate:allantoin ratio correlates positively
with maximum lifespan residual. The points
representing the naked mole rat and the Dam-
araland mole rat are indicated. Regression
p value.robust = 8.41 3 106; p value.max =
1.60 3 104.
(F) Liver kynurenine:tryptophan ratio correlates
negatively with maximum lifespan. Regression
p value.robust = 7.23 3 103; p value.max =
1.89 3 102.significant positive correlation with ML, ALres, and MLres in kid-
ney (p value.robust < 103; Figure 5E), indicating that long-lived
mammals had higher urate and lower allantoin levels. The ranges
of p values in kidney remain significant even when each species
was left out one at a time (p value.max = 1.21 3 102 for ML,
1.89 3 103 for ALres, and 1.60 3 104 for MLres; Table S4H),
so the observation is generally applicable across the examined
mammals and does not depend on any particular species. A pre-
vious study in primate and non-primate mammals also found a
significant positive correlation between ML potential and urate
concentration in serum and brain per specific metabolic rate
(Cutler, 1984). Interestingly, humans have the highest serum
urate level and are the longest-lived primates (Cutler, 1984).
The naked mole rat, the longest-lived rodent, also had very low
levels of uricase expression in liver (Figure 4C). Allantoin can338 Cell Metabolism 22, 332–343, August 4, 2015 ª2015 Elsevier Incalso be produced from urate by free radical oxidation (Kaur
and Halliwell, 1990), and studies on human samples suggest
high allantoin level may be a marker of oxidative stress (Kand’a´r
and Za´kova´, 2008; Yardim-Akaydin et al., 2006).
Liver concentrations of two tryptophan degradation products,
anthranilic acid and kynurenine, showed a robust negative corre-
lation with longevity (Table S4H). Over 95% of free tryptophan is
degraded via the kynurenine pathway, with the first rate-limiting
step catalyzed by indoleamine 2,3-dioxygenase (IDO) or trypto-
phan 2,3-dioxygenase (TDO). Anthranilic acid is produced from
enzymatic hydrolysis of kynurenine. Several studies have linked
tryptophan metabolism to aging and longevity. Knockdown of
tdo-2 gene in C. elegans can suppress the toxicity of aggrega-
tion-prone proteins and extend lifespan (van der Goot et al.,
2012). Fruit flies with TDO deficiency live significantly longer.
than wild-type controls (Oxenkrug, 2010). In mammals, reducing
dietary tryptophan can extend lifespan and delay age-related
changes in rats and mice (De Marte and Enesco, 1986; Segall
and Timiras, 1976), and the kynurenine:tryptophan ratio in hu-
mans increases with aging (Capuron et al., 2011; Frick et al.,
2004). In agreement, we also observed significant negative
correlation with longevity for the kynurenine:tryptophan ratio
and the anthranilic acid:tryptophan ratio in liver (Figure 5F;
Table S4H).
Reducing dietary amino acids levels has proved effective in
lifespan extension (Grandison et al., 2009; Lee et al., 2014; Min
and Tatar, 2006). Here, the amino acids in brain showed negative
correlation predominantly with FTM and FTMres (Table S4H),
implying that mammals that mature more slowly (and which
are usually also longer-lived) tend to have lower levels of brain
amino acids. The levels of branched chain amino acids such
as leucine and isoleucine are also low in long-lived Ames dwarf
mice (Wijeyesekera et al., 2012), which are defective in adenohy-
pophyseal development and have stunted growth. 4-pyridoxate
(catabolite of vitamin B6) in brain and thiamine (vitamin B1) in kid-
ney and liver also negatively correlated with lifespan (Table S4H).
They are required, respectively, for the synthesis of pyridoxal
phosphate (PLP) and thiamine pyrophosphate (TPP), which are
the essential cofactors for many enzymes involved in amino
acid metabolism (Eliot and Kirsch, 2004; Lonsdale, 2006). Over-
all, the result is consistent with reduced rate of mass-specific
metabolism in longer-lived mammals.
Insights from the Analysis of Long-Lived Mouse Models
To compare our results with established long-lived animal
models, we performed metabolite profiling on brain and liver tis-
sues of mice under caloric restriction (CR), rapamycin treatment
(RAP), and acarbose treatment (ACA), as well as GHRKO and
Snell dwarf mice (Snell), against their respective wild-type
controls under control diets (Table S1B). Five age-matched
(1 year old when sacrificed) biological replicates were collected
for each condition, with both males and females for CR, RAP,
and ACA and males only for GHRKO and Snell (Table S1B). In
total, 358 metabolites were reliably quantified across the 120
samples, and 241 of these metabolites overlapped with the
mammalian dataset (Figure S3).
We identified the metabolites differentially distributed be-
tween the long-lived mouse models and the corresponding con-
trols and performed pathway enrichment analysis (Figures 6A
and 6B; Table S5). The long-lived mouse model dataset clus-
tered with the mouse data in the mammalian dataset (Figure 6C),
indicating the overall metabolic signatures inherent in the spe-
cies were well preserved. Interestingly, while a significant num-
ber of top hits were found in liver, the brain metabolite levels
did not change much between the treatment and control (Fig-
ure 6A), and they were more conserved than those in liver
(Figure S3B). The blood-brain barrier may help keep the brain
metabolism in tight homeostasis and refractory to external mod-
ulations. The only exceptionwas the Snell mice, which are defec-
tive in anterior pituitary development. Compared to control, the
brain of Snell mice exhibits a shift from oxidative phosphorylation
toward glycolysis (Figure 6B).
In liver, CR, ACA, and Snell mice produced very similar meta-
bolic shifts, and these patterns were observed in both males andCelfemales (Figures 6A and 6B). Remarkably, there was extensive
reduction in PUFA TAG levels across all these three models (Fig-
ures 6B and 6D; Table S5C), which was consistent with the
longevity signature we identified across the mammalian species
and may indicate reduced susceptibility to peroxidation damage
and oxidative stress in the long-lived mice. While the low PUFA
TAG levels might be partly explained by the lower body weights
of these long-lived mice, this signature was not observed in
GHRKOdwarf mice or in RAPmice. Therewere no significant dif-
ferences in body weight among CR, RAP, and ACA in either
gender (Figure S3C). In addition, the long-lived mouse models
exhibited elevated levels of SM (in particular C14:0 SM, C16:0
SM, C18:0 SM and C18:1 SM), which also showed positive cor-
relation in longevity in the mammalian species dataset. Previ-
ously, SM levels were reported to be low in old mice but at
normal levels in those under chronic CR (De Guzman et al.,
2013) and were found to be high in the serum of centenarians
(Montoliu et al., 2014). High SM levels are also associated with
human female familial longevity (Gonzalez-Covarrubias et al.,
2013). Sphingosine-linked fatty acids like ceramides are often re-
garded as ‘‘damage-associated molecular patterns’’ and may
cause inflammatory damage by activating Nlrp3 inflammasome
(De Guzman et al., 2013; Vandanmagsar et al., 2011). Elevated
SM levels may also reflect reduced turnover to ceramides.
Other similarities as well as differences exist between our two
datasets and those in the literature. For example, methionine is
found at high levels in long-lived Ames dwarf mice, which may
represent an increased methionine flux to transsulfuration and
improved oxidative stress resistance (Wijeyesekera et al.,
2012). Methionine level is also high in brain of male CR mice
and liver of female ACA mice (Table S5). LPC levels were previ-
ously found to decrease with age but maintained in CR mice (De
Guzman et al., 2013); in both our datasets they were low in long-
lived animals. Furthermore, the mammalian dataset signatures
of high urate:allantoin ratio and low kynurenine:tryptophan ratio
were either insignificant or showed the opposite trends in the
mouse models (Table S5).
To quantify the similarity between the longevity signatures
from our two datasets, we counted the number of top hits in
both datasets that had the same direction of correlation to
longevity and compared that with the probability of getting
similar results by chance (Tables S5G–S5I). The liver signatures
of Snell, CR, and ACAmice matched very well to those based on
AL, ML, and FTM in kidney of the mammalian dataset (Figure 6E;
Tables S5H and S5I). In addition, these liver signatures also clus-
tered together (Figure 6F), suggesting lifespan extension by CR,
acarbose treatment, and in Snell mutants may affect certain
common pathways, where rapamycin treatment and growth hor-
mone receptor knockout may achieve lifespan extension via
different mechanisms.
DISCUSSION
Mammals have diversified dramatically over the tens of millions
of years of evolution with remarkably different longevity profiles.
How are their lifespans modulated by evolution while preserving
competitiveness within their ecological niches? Which metabo-
lites are involved and, more generally, how is metabolism
adjusted in order to increase lifespan? While most of thel Metabolism 22, 332–343, August 4, 2015 ª2015 Elsevier Inc. 339
Figure 6. Metabolites Differentially Distrib-
uted in Long-Lived Mouse Models
(A) Overview of metabolite differential distribution.
The grids represent the linear model p values for
differential distribution in the indicated long-lived
mousemodels with respect to their corresponding
controls in brain and liver (CR, caloric restric-
tion; RAP, rapamycin treatment; ACA, acarbose
treatment; GHRKO, growth hormone receptor
knockout; Snell, Snell dwarf mouse; F, female;
M, male). Only p values < 0.01 are shown in color,
with positive correlation in red and negative cor-
relation in blue. Selected classes of metabolites
are highlighted by rows (same color scheme as in
Figure 3A). See Table S5C for more details.
(B) Top enriched pathways. The grids represent
the pathway enrichment analysis p values (only
p values < 0.01 are shown in color), with positive
correlation in red and negative correlation in blue.
For brain, only Snell is shown. See Table S5F for
more details.
(C) Long-lived mouse model data cluster well with
mammalian species data. Values in parenthesis
indicate the percentage of variance explained by
each principal component (PC). Biological repli-
cates were treated as individual points.
(D) Liver C56:4 TAG level across the long-lived
mouse models. C56:4 TAG levels were significant
lower in CR(F) (p value = 2.21 3 105), CR(M)
(p value = 8.17 3 103), ACA(F) (p value = 7.22 3
103), and Snell (p value = 9.073 105), compared
to their respective controls.
(E) Overlap among longevity signatures. Between
each pair of comparison, the numbers of metab-
olites with matching and opposite direction of
correlation to longevity were calculated. p value
was based on binomial statistics, assuming equal
probability of getting a match or a mismatch by
chance. Only p values < 0.01 are shown in color.
See Table S5H for more details.
(F) Hierarchical clustering of the long-lived mouse
models. The distance matrix is based on the
similarity among the longevity signatures (i.e.,
pairwise binomial p values; Table S5H). Only the
liver data are shown. The mouse models are as
shown above.research on the control of lifespan was performed on single-
model organisms, our study addressed these questions by
analyzing metabolite levels in several organs across the class
of Mammalia. We found that metabolites in brain diverged less
than in the other examined organs and the organ-differential dis-
tribution of metabolites represented their respective biological
functions. The lineage-specific metabolite features we identified
reflect known physiology of animals (e.g., low oxidative stress in
bats) and also offer some new insights (e.g., bile acid conjugation
strategies among mammals and diminished conversion of urate
to allantoin in African mole rats). With regard to the longevity
traits, we identified metabolites previously implicated in lifespan
control as well as several new candidates. In particular, long-
lived mammals were associated with low polyunsaturated
TAGs, low tryptophan degradation products, and low brain
amino acids, as well as high sphingomyelin levels and a high
urate:allantoin ratio. Comparison of our signatures with the
metabolite changes in long-lived mouse models indicated340 Cell Metabolism 22, 332–343, August 4, 2015 ª2015 Elsevier Incsome overlap with mice under CR, mice treated with acarbose,
and Snell dwarf mice, especially for decrease in polyunsaturated
TAGs and increase in sphingomyelin. Similar changes were also
previously reported in studies on human centenarians and other
long-lived animal models. Furthermore, these three mouse
models produced metabolite signatures distinct from those
observed in rapamycin treatment and GHRKO mice, so the life-
span extension effects may have been achieved via different
mechanisms.
Our study also reveals some unexpected complexities in
analyzing metabolites and longevity. While some metabolites
show consistent correlation with longevity traits across multiple
organs, many patterns seem to be organ specific. In the long-
lived mouse models, many liver metabolites change significantly
compared to the controls, but the brain exhibits very little pertur-
bation. Furthermore, the longevity signatures in liver of the long-
lived mouse models matched with the kidney (but not liver)
signature across the mammalian species, suggesting certain.
aspects of the mammalian longevity signatures may be distinct
from the long-lived mouse models. In addition, the molecular
mechanisms underlying the lifespan extension in these mouse
models are not yet well delineated, and differences among
various long-livedmousemodels have been previously reported.
For example, in heart, kidney, and liver tissues, Snell and
GHRKO mice showed different levels of chaperone mRNAs
(Swindell et al., 2009). A low-calorie diet is beneficial to Ames
dwarf mice (Bartke et al., 2001), but not to GHRKO mice (Bon-
kowski et al., 2009). Expression of genes related to xenobiotic
detoxification in liver are distinctly different among rapamycin-
treated mice, CR mice (Miller et al., 2014), and GHR-deletion
mice (Li et al., 2013). CRmice also differ from rapamycin-treated
mice in terms of leptin, FGF-21, and glucose tolerance (Lamming
et al., 2013; Miller et al., 2014).
Compared with research that focuses on a single species, the
current study benefited from the large effects of trait differences.
While various factors such as feeding status, circadian cycle,
gender, and body weight differences can introduce additional
noise, ANOVA suggests that the variation between different spe-
cies is generally much greater than the variation among repli-
cates of the same species. Even with the ablation of GHR or
anterior pituitary, the brain and liver profiles of the long-lived
mice still clustered well with the mouse data in the mammalian
dataset, and very similar longevity signatures were also obtained
from both males and females of the same long-lived model.
However, our study also suffers from a number of limitations.
The current study does not prove causality between the metab-
olites and longevity traits, as the metabolite levels may influence
and also be influenced by longevity. The number of metabolites
quantified here only represents a fraction of the entire metabo-
lome space and potentially important candidates may have
beenmissed by our targeted approach. Manymetabolites corre-
lated strongly among one another and can inflate the signals
observed. Themetabolic fluxes through pathways and themeta-
bolic changes during aging would not be reflected in our data
either. While the biological implications of many metabolites
identified here are far from fully understood, our study provides
the first report of metabolite signatures of longevity across the
mammalian spectrum, from which future studies should benefit.EXPERIMENTAL PROCEDURES
Targeted metabolite profiling using three liquid chromatography-mass spec-
trometry (LC-MS)methods (Townsend et al., 2013) was applied to characterize
metabolites and lipids in brain, heart, kidney, and liver of 26 mammalian spe-
cies, as well as brain and liver tissues of five long-lived mouse models (Table
S1). For the mammalian species, guinea pig, rabbit, hamster, gerbil, and rat
were purchased from Charles River; naked mole rat, Damaraland mole rat,
mouse, white-footed mouse, shrew, primates, and bats were from our labora-
tories; and other species were as described previously (Fushan et al., 2015).
The samples were homogenates of freshly frozen tissues of sacrificed animals,
matched by age and sex; biological replicates (i.e., samples from multiple in-
dividuals of a species) were obtained for most species. All long-lived mouse
models as well as genotype and diet matched controls were from the colonies
at University of Michigan Medical School. Liver and brain cortex samples were
taken at 12months of age frommale and female mice treated from 4months of
agewith rapamycin (14.7 ppm, as inMiller et al., 2014) or acarbose (1,000 ppm,
as in Harrison et al., 2014), from mice subjected to 40% dietary restriction, or
from untreated littermate control mice of the genetically heterogeneous stock
UM-HET3. Liver and brain cortex samples from Snell dwarf (Flurkey et al.,Cel2001) and GHRKO (Coschigano et al., 2003) males, and their corresponding
littermate controls, were taken from young adults aged 4–6 months. Stringent
filtering, processing, and normalization procedures were applied to generate
the metabolome datasets (Data S1 and S2). Data quality was assessed graph-
ically (Figures S1 and S3).
Most of the phylogenetic and statistical analysis was performed using R
packages ‘‘phytools’’ (Revell, 2012) and ‘‘phylolm’’ (Ho and Ane´, 2014). Based
on LIPIDMAPS Classification System (Fahy et al., 2007), we grouped the lipids
as acylglycerols (diacylglycerol [DAG] and TAG), glycerophospholipids (PC,
PE, LPC, and LPE), sphingolipids (SM), and sterols (CE). Pathway enrichment
statistics were based on hypergeometric distribution and a 5,000-time boot-
strap procedure. For organ-differential distribution, we required a metabolite
to reach statistical significance in at least 2 organ pairs to qualify as a hit. To
identify lineage-specific distribution, a chosen group (based on taxonomical
order or family) was compared against all other species (unless otherwise
stated) by phylogenetic ANOVA.
Regression by generalized least-squares method was used to identify cor-
relation between longevity traits and metabolite levels and test four models
of trait evolution (Supplemental Experimental Procedures). We evaluated
the robustness of our results using a two-step verification procedure. First,
regression was repeated by excluding the point with largest residue error
(‘‘p value.robust’’), so that the overall relationship was not skewed by a poten-
tial outlier. Next, each species was left out, one at a time, and regression was
performed on the remaining species to calculate the maximal (i.e., least signif-
icant) p value (‘‘p value.max’’), ensuring that the correlation was generalizable
and did not depend on a single species. For the long-lived mouse models,
differentially distributed metabolites between treatment and the correspond-
ing control samples were identified. Overlap among the longevity signatures
was assessed by binomial statistics and a 5,000-times bootstrap. Detailed
experimental procedures can be found in Supplemental Experimental
Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, five tables, and two datasets and can be found with this article
online at http://dx.doi.org/10.1016/j.cmet.2015.07.005.
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